Asia Pacific Intravenous (IV) Therapy and Vein Access Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Ambulatory Surgical Center, and Clinics), By Application, By Type, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Intravenous (IV) Therapy and Vein Access Market
Market Report Description
The Asia Pacific Intravenous (IV) Therapy and Vein Access Market would witness Market growth of 6.0% CAGR during the forecast period (2022-2028).
Chronic disease incidence is on the rise, as are traffic accidents and trauma cases. In addition, the expansion of the Intravenous Therapy and Vein Access Market is predicted to be fueled by an increase in healthcare spending and insurance throughout the forecast period. However, the Market 's expansion is hampered by a scarcity of experienced healthcare workers. The increase in critical care therapies and the rise in the elderly population, on the other hand, are important drivers driving the Intravenous Therapy and Vein Access Market .
Infusion pumps, IV sets, and needleless connectors are the three product categories that are critical for the Market . Implantable ports, port needles, central venous catheters, dialysis catheters, peripherally implanted central catheters, peripheral intravenous catheters, syringes, and needles are all part of the vascular access devices Market , also known as vein access devices. Central venous catheters (CVC) are the fastest-growing segment of vascular access devices in European countries. Because of the growing number of patients who require long-term indwelling catheters, the demand for antimicrobial CVCs is much larger than for regular CVCs. In North America and Europe, peripheral intravenous catheters (PIVC) are also widely popular.
An increase in the number of surgeries performed in the region would act as the key growth catalyst for the regional Market . The All-India Institute of Medical Science (AIIMS) announced that it performed 1.94 lakh procedures in 2018, making it the institute with the most surgeries performed globally in that year. One of the key trends in the regional Market is the demand for improved technology and the rising prevalence of renal illnesses and diabetes.
The intravenous (IV) therapy and vein access device devices in the Asia Pacific are quickly expanding. China, India, and Indonesia are among the countries in this area that are seeing tremendous economic expansion. Due to the rising prevalence of chronic diseases such as cancer and diabetes, intravenous (IV) therapy and vein access devices are becoming increasingly popular throughout the Asia Pacific.
The China Market dominated the Asia Pacific Intravenous (IV) Therapy and Vein Access Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $2,891.7 million by 2028. The Japan Market is poised to grow at a CAGR of 5.3% during (2022 - 2028). Additionally, The India Market would display a CAGR of 6.7% during (2022 - 2028).
Based on End User, the Market is segmented into Hospitals, Ambulatory Surgical Center, and Clinics. Based on Application, the Market is segmented into Medication Administration, Blood Based Products, Nutrition & Buffer Solution, and Volume Expander. Based on Type, the Market is segmented into Intravenous Catheters, Infusion Pumps, Hypodermic Needles, Implantable Ports, and Others. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC, and AngioDynamics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Ambulatory Surgical Center
- Medication Administration
- Blood Based Products
- Nutrition & Buffer Solution
- Volume Expander
- Intravenous Catheters
- Infusion Pumps
- Hypodermic Needles
- Implantable Ports
- South Korea
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- B. Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Fresenius SE & Co. KGaA
- Cardinal Health, Inc.
- Pfizer, Inc.
- Teleflex, Inc.
- Baxter International, Inc.
- Smiths Group PLC
- AngioDynamics, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free